Whatman to Debut Its First Diagnostic Chip in Europe in Q1; US to Follow | GenomeWeb

SAN DIEGO — Whatman, a UK-owned array company known for its microarray slide technology, will launch a protein-based diagnostic chip for autoimmune diseases this quarter, according to a company official.

Michael Harvey, Whatman's principal scientist, said that his company will begin selling the array, called CombiChip, to reference laboratories in Europe this quarter, marking Whatman's first foray into the diagnostic space. Harvey made his comments at Cambridge Healthtech Institute's annual PepTalk conference, held here last week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.